Company Profile

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE152.45-1.9 (-1.23 % )
PREV CLOSE (Rs.) 154.35
OPEN PRICE (Rs.) 157.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 82771
TODAY'S LOW / HIGH (Rs.)151.00 157.55
52 WK LOW / HIGH (Rs.) 70.05 218.7
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.90
TTM EPS (Rs.) 5.31
P/E Ratio 28.70
Book Value (Rs.) 37.02
Face Value (Rs.) 5
MCap (Rs. in Mn) 7639.57
Price/Earning (TTM) 18.21
Price/Sales (TTM) 1.88
Price/Book (MRQ) 4.12
PAT Margin (%) 4.50
ROCE (%) 10.87
Incorporation Year : 1960

Management Info :

Jasvantlal G Shah - Chairman - Managing Director

Registered Office :

Address : 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone : +91-22-66227575

Email : anuh@sk1932.com

Website : www.anuhpharma.com

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
11May05-11-2021$Anuh Pharma informs about newspaper advertisement Anuh Pharma informs about ne
Anuh Pharma has informed that it enclosed copies of newspaper advertisement with respect to the Notice of Board Meeting to be held on Friday, 21st May, 2021 published in the English Newspaper, Financial Express and in Marathi Newspaper, Mumbai Lakshadeep on Monday, May 10, 2021 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Anuh Pharma has informed that it enclosed copies of newspaper a..
10May05-10-2021$ Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Board Meeting Intimation fo
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 21st May, 2021, inter alia: 1)To consider and approve Audited Financial Results of the Company for the quarter & year ended 31st March, 2021; and 2) To consider and recommend final Dividend, if any, for the financial year 2020-21.
ANUH PHARMA LTD.has informed BSE that the meeting of the Board..
04May05-04-2021$Anuh Pharma informs about newspaper publication regarding IEPF Anuh Pharma informs about ne

Anuh Pharma has informed that it has enclosed the copies of newspaper advertisement published on May 04, 2021 in the newspapers, ‘Financial Express and Mumbai Lakshadeep’. This Notice was published pursuant to the provisions of the Investor Education and Protection Fund (IEPF) Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (the Rules) notified by the Ministry of Corporate Affairs effective September 07, 2016 and amendments thereof.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma has informed that it has enclosed the copies of new..
30Sep09-30-2020$Anuh Pharma jumps on getting approval for Pyrimcthamine API Anuh Pharma jumps on getting

Anuh Pharma is currently trading at Rs. 194.50, up by 4.60 points or 2.42% from its previous closing of Rs. 189.90 on the BSE.

The scrip opened at Rs. 194.45 and has touched a high and low of Rs. 195.30 and Rs. 186.00 respectively. So far 22586 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 218.70 on 25-Aug-2020 and a 52 week low of Rs. 48.70 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 207.80 and Rs. 182.00 respectively. The current market cap of the company is Rs. 967.66 crore.

The promoters holding in the company stood at 72.09%, while Non-Institutions held 27.90% stake in the company.

Anuh Pharma has received approval from World Health Organization (WHO) - Geneva Prequalification for Pyrimcthamine API which is used as Anti - Malarial Durgs.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma is currently trading at Rs. 194.50, up by 4.60 poin..
29Sep09-29-2020$Anuh Pharma gets approval for Pyrimcthamine API Anuh Pharma gets approval fo

Anuh Pharma has received approval from World Health Organization (WHO) - Geneva Prequalification for Pyrimcthamine API which is used as Anti - Malarial Durgs.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma has received approval from World Health Organizatio..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit41.7999999999999143.05
Gross Profit 46.9899999999999 191.55
Operating Profit 89.1999999999999269.8
Net Sales 983.33069.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Hester Biosciences (BSE)
 2470.05 (11.53%)
M.Cap ( in Cr)
2101.24
Astrazeneca Pharma I (BSE)
 3840.05 (2.70%)
M.Cap ( in Cr)
9600.13
Themis Medicare (BSE)
 497.30 (6.82%)
M.Cap ( in Cr)
456.94
Caplin Point Lab (BSE)
 591.05 (4.82%)
M.Cap ( in Cr)
4470.86
Glaxosmithkline Phar (BSE)
 1503.80 (1.65%)
M.Cap ( in Cr)
25475.28
Shareholding Pattern More
PROMOTERS 70.47 %
NON-INSTITUTION 29.53 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Nippon India Pharma Fun...2.44
F & O Quotes